Epidiolex
Chemical Name | cannabidiol |
Dosage Form | Solution (oral; 100 mg/mL) |
Drug Class | Miscellaneous |
System | Nervous |
Company | Greenwich Biosciences |
Approval Year | 2018 |
Indication
- Epidiolex is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous sclerosis complex in patients 1 year of age and older.